L. Vo

524 total citations
17 papers, 395 citations indexed

About

L. Vo is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Vo has authored 17 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Infectious Diseases and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Vo's work include Atrial Fibrillation Management and Outcomes (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). L. Vo is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). L. Vo collaborates with scholars based in United States, United Kingdom and Canada. L. Vo's co-authors include Benjamin A. Lipsky, R.S. Johannes, J. Weigelt, Ying P. Tabak, Rabih O. Darouiche, Gunnar Sandström, Paul R. Georghiou, Ribhi M. Shawar, Jill E. Clarridge and Xuemei Luo and has published in prestigious journals such as Journal of Clinical Microbiology, Diabetologia and Annals of Oncology.

In The Last Decade

L. Vo

14 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Vo United States 8 101 96 90 63 59 17 395
Juan Diego Mediavilla Spain 10 31 0.3× 45 0.5× 120 1.3× 38 0.6× 72 1.2× 15 452
Sherman S. Leung Australia 5 335 3.3× 79 0.8× 14 0.2× 38 0.6× 38 0.6× 8 708
Angelika Dübbers Germany 13 106 1.0× 214 2.2× 72 0.8× 16 0.3× 32 0.5× 17 487
Marie Lagrange-Xélot France 10 184 1.8× 30 0.3× 81 0.9× 19 0.3× 11 0.2× 27 369
S. Gayet France 10 240 2.4× 148 1.5× 83 0.9× 4 0.1× 9 0.2× 31 496
Sharon Kuzi Israel 13 36 0.4× 44 0.5× 24 0.3× 14 0.2× 8 0.1× 28 384
Selma Gökahmetoğlu Türkiye 14 71 0.7× 38 0.4× 29 0.3× 36 0.6× 10 0.2× 59 417
Yoshikiyo Ito Japan 15 84 0.8× 76 0.8× 42 0.5× 4 0.1× 9 0.2× 41 571
C. L. Jones Australia 11 54 0.5× 128 1.3× 30 0.3× 44 0.7× 8 0.1× 20 401
Uffe Vest Schneider Denmark 13 147 1.5× 99 1.0× 35 0.4× 4 0.1× 19 0.3× 31 411

Countries citing papers authored by L. Vo

Since Specialization
Citations

This map shows the geographic impact of L. Vo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Vo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Vo more than expected).

Fields of papers citing papers by L. Vo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Vo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Vo. The network helps show where L. Vo may publish in the future.

Co-authorship network of co-authors of L. Vo

This figure shows the co-authorship network connecting the top 25 collaborators of L. Vo. A scholar is included among the top collaborators of L. Vo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Vo. L. Vo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Atkinson, C., et al.. (2025). Paediatric ballistic fracture patients: who has poor follow-up and why?. International Orthopaedics. 49(6). 1451–1460. 1 indexed citations
2.
3.
4.
5.
Deitelzweig, Steve, Caroline Farmer, Xuemei Luo, et al.. (2017). Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. Current Medical Research and Opinion. 33(9). 1583–1594. 24 indexed citations
6.
Deitelzweig, Steven, Caroline Farmer, Xuemei Luo, et al.. (2017). Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis. Current Medical Research and Opinion. 34(3). 487–498. 37 indexed citations
7.
Amin, Alpesh, Allison Keshishian, Lin Xie, et al.. (2015). Comparison of major-bleeding risk and health care costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban, or warfarin. MEF University Institutional Repository (MEF University). 2 indexed citations
8.
9.
Lipsky, Benjamin A., et al.. (2014). Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors. Diagnostic Microbiology and Infectious Disease. 79(2). 273–279. 30 indexed citations
10.
Lipsky, Benjamin A., Lena M. Napolitano, Gregory J. Moran, et al.. (2014). Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study. Diagnostic Microbiology and Infectious Disease. 79(2). 266–272. 24 indexed citations
11.
Ward, Anne, et al.. (2013). Direct medical costs of diabetic complications in the United States. Value in Health. 16(3). A188–A188. 1 indexed citations
12.
13.
Crivera, Concetta, Dong‐Churl Suh, Edmund Huang, et al.. (2006). The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients. Current Medical Research and Opinion. 22(11). 2301–2311. 4 indexed citations
14.
15.
Vo, L., et al.. (2005). PDB8 PREVALENCE OF DIABETES MELLITUS AND TREATMENT PATTERNS BASED ON CLASSIFICATION OF BODY MASS INDEX AMONG ADULTS. Value in Health. 8(3). 354–354. 1 indexed citations
16.
Vo, L.. (2001). Automated in situ hybridisation using Tecan robotics: a kick-start for Functional Genomics. JALA Journal of the Association for Laboratory Automation. 6(4). 59–61. 1 indexed citations
17.
Clarridge, Jill E., Gunnar Sandström, Rabih O. Darouiche, et al.. (1996). Characterization of two unusual clinically significant Francisella strains. Journal of Clinical Microbiology. 34(8). 1995–2000. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Diego Mediavilla Breakdown of academic impact, for papers by Sherman S. Leung Breakdown of academic impact, for papers by Angelika Dübbers Breakdown of academic impact, for papers by Marie Lagrange-Xélot Breakdown of academic impact, for papers by S. Gayet Breakdown of academic impact, for papers by Sharon Kuzi Breakdown of academic impact, for papers by Selma Gökahmetoğlu Breakdown of academic impact, for papers by Yoshikiyo Ito Breakdown of academic impact, for papers by C. L. Jones Breakdown of academic impact, for papers by Uffe Vest Schneider
Rankless by CCL
2026